Negative effect of parecoxib on bone mineral during fracture healing in rats.

Item

http://www.wikidata.org/entity/Q46484081

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh-hant

name

Negative effect of parecoxib on bone mineral during fracture healing in rats.

@en

Negative effect of parecoxib on bone mineral during fracture healing in rats.

@nl

type

Item

label

Negative effect of parecoxib on bone mineral during fracture healing in rats.

@en

Negative effect of parecoxib on bone mineral during fracture healing in rats.

@nl

prefLabel

Negative effect of parecoxib on bone mineral during fracture healing in rats.

@en

Negative effect of parecoxib on bone mineral during fracture healing in rats.

@nl

P1476

Negative effect of parecoxib on bone mineral during fracture healing in rats.

@en

P2093

Harald Steen

http://www.w3.org/2001/XMLSchema#string

Jan Erik Madsen

http://www.w3.org/2001/XMLSchema#string

Lars Nordsletten

http://www.w3.org/2001/XMLSchema#string

Sigbøjrn Dimmen

http://www.w3.org/2001/XMLSchema#string

P2860

N-[[(5-methyl-3-phenylisoxazol-4-yl)-phenyl]sulfonyl]propanamide, sodium salt, parecoxib sodium: A potent and selective inhibitor of COX-2 for parenteral administration

The injectable cyclooxygenase-2-specific inhibitor parecoxib sodium has analgesic efficacy when administered preoperatively.

The second generation of COX-2 inhibitors: what advantages do the newest offer?

Patients' global evaluation of analgesia and safety of injected parecoxib for postoperative pain: a quantitative systematic review.

Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain.

Pharmacokinetic-pharmacodynamic correlations and biomarkers in the development of COX-2 inhibitors.

Prostaglandin G/H synthase-2 is required for maximal formation of osteoclast-like cells in culture.

Differential inhibition of fracture healing by non-selective and cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs.

Parecoxib sodium, a parenteral cyclooxygenase 2 selective inhibitor, improves morphine analgesia and is opioid-sparing following total hip arthroplasty.

Parecoxib sodium has opioid-sparing effects in patients undergoing total knee arthroplasty under spinal anaesthesia.

P304

438-444

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/17453670710015373

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Lars Engebretsen

P577

2008-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5225128

http://www.w3.org/2001/XMLSchema#string

P698

18626809

http://www.w3.org/2001/XMLSchema#string